All News

When Express Scripts and CVS Health announced their 2017 formularies on August 1, a common theme emerged among the healthcare giants: several blockbuster drugs will be removed from both companies’ formularies and lower-cost options such as biosimilars are being embraced.

FDA approved Onzetra Xsail (Avanir Pharmaceuticals Inc.)- a fast-acting, low-dose sumatriptan dry powder formulation for the acute treatment of migraine with or without aura in adults.

Americans spend billions of dollars on products to address specific hair and scalp concerns each year-whether that be color, condition, or appearance.

Community pharmacists are caught in the middle of a battle between patients and their health insurers over how the federal government defines medical foods and how patients are paying for them.

According to FDA and other sources, tobacco use is the single largest preventable cause of disease and death in the United States.

Occasionally, it can be interesting to learn what pharmacists and other insiders foresee as the industry’s future

An exclusive Associated Press report found that Medicare’s spending on certain drugs soared by 85% in two years.

The rate of breastfeeding has reached over 75% in the U.S. The goal set by Healthy People 2020 is 82%. The Surgeon General has released a “call to action” that promotes breastfeeding for every mother who wishes to do so.

Helping pharmacists perform at the top of their licenses and be reimbursed for services such as medication therapy management (MTM) are among the goals of the National Community Pharmacist Association’s (NCPA) Innovation Center.

People are looking--and judging.

Retail pharmacies are in the news a lot these days. Unfortunately, it is not the kind of news anyone wants to hear.

As bacterial meningitis spikes in certain regions of the U.S. and with more schools recommending vaccination, some pharmacy chains are helping to combat the disease.

Physicians and pharmacists welcomed FDA’s recent approval of etanercept-szzs (Erelzi), a biosimilar to Amgen’s top-selling Enbrel for rheumatoid arthritis, plaque psoriasis, and other inflammatory conditions.

FDA’s method for naming biosimilars and interchangeable biologics came under fire long before the first biosimilar, Zarxio, was approved last spring.

Why are Rx drugs so expensive? No one seems to have a good answer.

Researchers reported that nearly half of cigarette smokers, as well as nearly half of tobacco users who don’t smoke cigarettes, support such a policy.

Both brick-and-mortar and mail-order pharmacies receive high scores when it comes to customer satisfaction, according to J.D. Power’s 2016 U.S. Pharmacy Study.

Pharmacist intervention is one primary way that adherence to cholesterol-lowering medications can be improved in minority neighborhoods, a recent study found.

New study finds that biosimilar medications for arthritis and other diseases areas safe and effective as their brand-name counterparts.

New branded drugs, new generics.

Dennis Song, RPh, describes the steps to take when starting a compounding services business.

Pharmacists and other healthcare professionals are looking to the FDA for more guidance on biosimilars and interchangeability with their reference products.

Anxious new pharmacists get a shot in the arm from columnist Pete Kreckel, RPh.

The issues of most concern to pharmacists, outlined at McKesson’s ideaShare 2016.

Despite barriers to their adoption in the U.S. and Europe, biosimilars have produced healthcare savings in Europe. Similar savings are projected for the U.S. market.

A coordinated effort needs to be made to preserve the health and safety of life on earth.

Cancer treatments are expected to dominate much of the first wave of biosimilars in the U.S. This Q&A discussion looks at some of the questions pharmacists have about use of biosimilars in cancer treatment.